» Articles » PMID: 22245770

Hemin Causes Mitochondrial Dysfunction in Endothelial Cells Through Promoting Lipid Peroxidation: the Protective Role of Autophagy

Overview
Authors
Affiliations
Soon will be listed here.
Abstract

The hemolysis of red blood cells and muscle damage results in the release of the heme proteins myoglobin, hemoglobin, and free heme into the vasculature. The mechanisms of heme toxicity are not clear but may involve lipid peroxidation, which we hypothesized would result in mitochondrial damage in endothelial cells. To test this, we used bovine aortic endothelial cells (BAEC) in culture and exposed them to hemin. Hemin led to mitochondrial dysfunction, activation of autophagy, mitophagy, and, at high concentrations, apoptosis. To detect whether hemin induced lipid peroxidation and damaged proteins, we used derivatives of arachidonic acid tagged with biotin or Bodipy (Bt-AA, BD-AA). We found that in cells treated with hemin, Bt-AA was oxidized and formed adducts with proteins, which were inhibited by α-tocopherol. Hemin-dependent mitochondrial dysfunction was also attenuated by α-tocopherol. Protein thiol modification and carbonyl formation occurred on exposure and was not inhibited by α-tocopherol. Supporting a protective role of autophagy, the inhibitor 3-methyladenine potentiated cell death. These data demonstrate that hemin mediates cytotoxicity through a mechanism which involves protein modification by oxidized lipids and other oxidants, decreased respiratory capacity, and a protective role for the autophagic process. Attenuation of lipid peroxidation may be able to preserve mitochondrial function in the endothelium and protect cells from heme-dependent toxicity.

Citing Articles

Major heme proteins hemoglobin and myoglobin with respect to their roles in oxidative stress - a brief review.

Sil R, Chakraborti A Front Chem. 2025; 13:1543455.

PMID: 40070406 PMC: 11893434. DOI: 10.3389/fchem.2025.1543455.


Lipid Coating Modulates Effects of Nanoceria on Oxidative Metabolism in Human Embryonic Lung Fibroblasts: A Case of Cardiolipin.

Proskurnina E, Sozarukova M, Ershova E, Savinova E, Kameneva L, Veiko N Biomolecules. 2025; 15(1).

PMID: 39858447 PMC: 11764243. DOI: 10.3390/biom15010053.


Potential of Enzymatically Synthesized Hemozoin Analog as Th1 Cell Adjuvant.

Hoshi K, Tu A, Shobo M, Kettisen K, Ye L, Bulow L Nanomaterials (Basel). 2024; 14(17).

PMID: 39269102 PMC: 11397214. DOI: 10.3390/nano14171440.


ROCK Inhibitor Fasudil Attenuates Neuroinflammation and Associated Metabolic Dysregulation in the Tau Transgenic Mouse Model of Alzheimer's Disease.

Ouyang X, Collu R, Benavides G, Tian R, Darley-Usmar V, Xia W Curr Alzheimer Res. 2024; 21(3):183-200.

PMID: 38910422 DOI: 10.2174/0115672050317608240531130204.


Hemopexin reverses activation of lung eIF2α and decreases mitochondrial injury in chlorine-exposed mice.

Matalon S, Yu Z, Dubey S, Ahmad I, Stephens E, Alishlash A Am J Physiol Lung Cell Mol Physiol. 2023; 326(4):L440-L457.

PMID: 38150547 PMC: 11281818. DOI: 10.1152/ajplung.00273.2023.


References
1.
Nakayama M, Takahashi K, Komaru T, Fukuchi M, Shioiri H, Sato Ki . Increased expression of heme oxygenase-1 and bilirubin accumulation in foam cells of rabbit atherosclerotic lesions. Arterioscler Thromb Vasc Biol. 2001; 21(8):1373-7. DOI: 10.1161/hq0801.093592. View

2.
Go Y, Levonen A, Moellering D, Ramachandran A, Patel R, Jo H . Endothelial NOS-dependent activation of c-Jun NH(2)- terminal kinase by oxidized low-density lipoprotein. Am J Physiol Heart Circ Physiol. 2001; 281(6):H2705-13. DOI: 10.1152/ajpheart.2001.281.6.H2705. View

3.
Nagel R, GIBSON Q . The binding of hemoglobin to haptoglobin and its relation to subunit dissociation of hemoglobin. J Biol Chem. 1971; 246(1):69-73. View

4.
Fujita N, Hayashi-Nishino M, Fukumoto H, Omori H, Yamamoto A, Noda T . An Atg4B mutant hampers the lipidation of LC3 paralogues and causes defects in autophagosome closure. Mol Biol Cell. 2008; 19(11):4651-9. PMC: 2575160. DOI: 10.1091/mbc.e08-03-0312. View

5.
Fucharoen S, Ketvichit P, Pootrakul P, Siritanaratkul N, Piankijagum A, Wasi P . Clinical manifestation of beta-thalassemia/hemoglobin E disease. J Pediatr Hematol Oncol. 2000; 22(6):552-7. DOI: 10.1097/00043426-200011000-00022. View